Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-740-9 | CAS number: 87-33-2
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics
- Type of information:
- other: information from secondary source
- Adequacy of study:
- key study
- Study period:
- 2011
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- A reliable secondary source, summarising ISDN pharmaco-toxicological properties, was used. However, the primary sources were not revisited in order to verify their contents; for this reason reliability score 2 was used. The used secondary source has been updated on January, 2011; therefore it covers the most updated literature on the substance.
Data source
Referenceopen allclose all
- Reference Type:
- secondary source
- Title:
- No information
- Bibliographic source:
- Physicians' desk reference
- Reference Type:
- secondary source
- Title:
- No information
- Year:
- 2 011
- Bibliographic source:
- Drugdex Drug Evaluation: DRUGDEX® System. Thomson Reuters, Greenwood Village, Colorado.
Materials and methods
- Objective of study:
- other: assessment of pharmacokinetic parameters
Test guideline
- Qualifier:
- no guideline available
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Isosorbide dinitrate
- EC Number:
- 201-740-9
- EC Name:
- Isosorbide dinitrate
- Cas Number:
- 87-33-2
- Molecular formula:
- C6H8N2O8
- IUPAC Name:
- isosorbide dinitrate
Constituent 1
Results and discussion
Toxicokinetic / pharmacokinetic studies
Toxicokinetic parametersopen allclose all
- Test no.:
- #1
- Toxicokinetic parameters:
- half-life 1st: about 4 h for elimination
- Test no.:
- #2
- Toxicokinetic parameters:
- other: The distribution volume is 2-4 L/Kg
- Test no.:
- #3
- Toxicokinetic parameters:
- other: The clearance is 2-4 L/min
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- There are two metabolites: isosorbide-2-mononitrate (half life is about 2 hours) and isosorbide-5-mononitrate (half life is about 5 hours).
Any other information on results incl. tables
After oral administration of both single and repeated doses (15, 30, 60 and 120 mg four times daily) of ISDN, peak serum levels are observed after 0.5 to 1 hours. Oral bioavailability ranges from 22% to 59%; it may be affected by food (reduced absorption); multiple-dose studies of ingested ISDN have shown progressive increases in bioavailability during chronic administration.
Protein binding is minimal. In humans the volume of distribution ranges from 48 to 473 liters (2 -4 L/kg). ISDN is metabolized to isosorbide-5-mononitrate and to isosorbide-2-mononitrate. The excretion is mainly renal (80% to 90% of the administered dose): the majority is excreted as conjugated metabolites within 24 hours . Total body clearance is 2 -4 liters/minute. During chronic administration, clearance decreased with increasing dose. The elimination half-life after oral administration is 4 hours.The daily dose-free interval is at least 14 hours due to the half-lives of ISDN and its active metabolites.
Applicant's summary and conclusion
- Executive summary:
After oral administration of both single and repeated doses (15, 30, 60 and 120 mg four times daily) of ISDN, peak serum levels are observed after 0.5 to 1 hours. Oral bioavailability ranges from 22% to 59%; it may be affected by food (reduced absorption); multiple-dose studies of ingested ISDN have shown progressive increases in bioavailability during chronic administration.
Protein binding is minimal. In humans the volume of distribution ranges from 48 to 473 liters (2 -4 L/kg). ISDN is metabolized to isosorbide-5-mononitrate and to isosorbide-2-mononitrate. The excretion is mainly renal (80% to 90% of the administered dose): the majority is excreted as conjugated metabolites within 24 hours . Total body clearance is 2 -4 liters/minute. During chronic administration, clearance decreased with increasing dose. The elimination half-life after oral administration is 4 hours.The daily dose-free interval is at least 14 hours due to the half-lives of ISDN and its active metabolites.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
